Luna-Ortiz Kuauhyama, Villavicencio-Valencia Verónica, Pasche Philippe, Lavin-Lozano Arturo, Herrera-Gómez Angel
Department of Head and Neck Surgery, Instituto Nacional de Cancerología, México, DF México.
Acta Otorrinolaringol Esp. 2011 Mar-Apr;62(2):113-8. doi: 10.1016/j.otorri.2010.09.016. Epub 2010 Dec 31.
BACKGROUND: To compare clinical and demographic data between laryngeal cancer patients younger and older than 40 years old. METHODS: Is a matched-paired study, realized from 1989 to 2002. We selected 500 laryngeal cancer patients treated in the National Cancer Institute of Mexico. Fifteen cases of patients younger than 40 years that accomplished inclusion criteria were identified, pair-matched and compared by clinical stage with 33 patients older than 40 years. We analyzed demographic factors and disease-free and Overall Survival by Kaplan-Meier method. RESULTS: We included 9 male and 6 female patients with a mean age of 34 years in contrast to a mean age of 62 years in the comparison group. Four cases in clinical stage I, none clinical stage II, 6 in stage III and 5 in stage IV were included in the younger group and compared to 8 patients in stage I, 15 in stage III and 10 in stage IV in the older group. No differences in demographic variables or lifestyle habits were found. All patients in stage I, are alive in both groups. Disease-free survival not show any differences when comparing stages III and IV (p=NS). Mean disease-free survival was 66 months and mean overall survival was 83 months in the younger group. CONCLUSION: Laryngeal carcinoma is rare in patients younger than 40 years. No gender, clinical or prognostic differences could be identified among the two groups. The prognosis of these patients seems to be only determined by the initial clinical stage.
背景:比较40岁及以上与40岁以下喉癌患者的临床和人口统计学数据。 方法:这是一项1989年至2002年进行的配对研究。我们选取了在墨西哥国家癌症研究所接受治疗的500例喉癌患者。确定了15例年龄小于40岁且符合纳入标准的患者,与33例年龄大于40岁的患者进行配对,并按临床分期进行比较。我们采用Kaplan-Meier方法分析了人口统计学因素、无病生存期和总生存期。 结果:我们纳入了9例男性和6例女性患者,平均年龄为34岁,而对照组的平均年龄为62岁。年轻组纳入临床I期4例、无II期病例、III期6例、IV期5例,并与老年组I期8例、III期15例、IV期10例进行比较。未发现人口统计学变量或生活方式习惯存在差异。两组I期的所有患者均存活。比较III期和IV期时,无病生存期未显示出任何差异(p=无统计学意义)。年轻组的平均无病生存期为66个月,平均总生存期为83个月。 结论:40岁以下患者喉癌罕见。两组之间未发现性别、临床或预后差异。这些患者的预后似乎仅由初始临床分期决定。
Acta Otorrinolaringol Esp. 2011
ORL J Otorhinolaryngol Relat Spec. 2007
J Otolaryngol. 1989-12
Laryngoscope. 2005-8
Am J Clin Oncol. 2010-12